Cargando…

Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome

Background: Pharmacological treatment of obesity and glucose-insulin metabolism disorders in children may be more difficult than in adults. Thus, we evaluate the effects of metformin in comparison with metformin plus a polysaccharide complex (Policaptil Gel Retard(®), PGR) on body weight and metabol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stagi, Stefano, Ricci, Franco, Bianconi, Martina, Sammarco, Maria Amina, Municchi, Giovanna, Toni, Sonia, Lenzi, Lorenzo, Verrotti, Alberto, de Martino, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452254/ https://www.ncbi.nlm.nih.gov/pubmed/28531113 http://dx.doi.org/10.3390/nu9050524

Ejemplares similares

Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY
Publicado: (2013)

Comment on: TODAY Study Group. Effects of Metformin, Metformin Plus Rosiglitazone, and Metformin Plus Lifestyle on Insulin Sensitivity and β-Cell Function in TODAY. Diabetes Care 2013;36:1749–1757
por: Baldi, James C., et al.
Publicado: (2013)

Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

50 Metformin versus Insulin: Glucose Control and Safety in Burn Patients
por: Hallman, Taylor, et al.
Publicado: (2023)

Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

An Overview on Different L-Thyroxine (l-T(4)) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life
por: Stagi, Stefano, et al.
Publicado: (2022)

A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus
por: Tandon, Tanya, et al.
Publicado: (2019)

Evaluation of Apelin and Insulin Resistance in Patients with PCOS and Therapeutic Effect of Drospirenone-Ethinylestradiol Plus Metformin
por: Sun, Xianchang, et al.
Publicado: (2015)

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

Type II diabetes and impaired glucose tolerance due to severe hyperinsulinism in patients with 1p36 deletion syndrome and a Prader-Willi-like phenotype
por: Stagi, Stefano, et al.
Publicado: (2014)

Bone Status in a Patient with Insulin-Like Growth Factor-1 Receptor Deletion Syndrome: Bone Quality and Structure Evaluation Using Dual-Energy X-Ray Absorptiometry, Peripheral Quantitative Computed Tomography, and Quantitative Ultrasonography
por: Pelosi, Paola, et al.
Publicado: (2017)

Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes
por: Ji, Ming, et al.
Publicado: (2016)

Response to Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Letter]
por: Panjaitan, Novaria Sari Dewi, et al.
Publicado: (2022)

Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
por: DeFronzo, Ralph A., et al.
Publicado: (2010)

Phosphodiesterase 4 inhibitor plus metformin is superior to metformin alone for the treatment of polycystic ovary syndrome: A rat model study
por: Tohma, Yusuf Aytac, et al.
Publicado: (2019)

Insulin and Metformin Regulate Circulating and Adipose Tissue Chemerin
por: Tan, Bee K., et al.
Publicado: (2009)

Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
por: Bruckbauer, Antje, et al.
Publicado: (2013)

Effect of metformin on insulin-resistant endothelial cell function
por: CHEN, HAIYAN, et al.
Publicado: (2015)

Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance
por: Du, Xuan, et al.
Publicado: (2018)

Metformin paradoxically worsens insulin resistance in SHORT syndrome
por: Lewandowski, Krzysztof C., et al.
Publicado: (2019)

Glucose-responsive Insulinoma with Insulin Hypersecretion Suppressed by Metformin
por: Hamano, Kunihisa, et al.
Publicado: (2019)

Anaphylactic reaction to gonadotropin‐releasing hormone analogues: a pediatric case report
por: Ricci, Franco, et al.
Publicado: (2018)

Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study
por: Lim, Soo, et al.
Publicado: (2023)

Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
por: Caturano, Alfredo, et al.
Publicado: (2023)

Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia
por: Shan, Weiwei, et al.
Publicado: (2014)

Hyperinsulinism
Publicado: (1932)

Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy
por: Inzucchi, S. E., et al.
Publicado: (2015)

Combined intervention of swimming plus metformin ameliorates the insulin resistance and impaired lipid metabolism in murine gestational diabetes mellitus
por: Huang, Liping, et al.
Publicado: (2018)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Effects of Metformin and Exercise Training, Alone or in Combination, on Cardiac Function in Individuals with Insulin Resistance
por: Cadeddu, Christian, et al.
Publicado: (2016)

Pharmacokinetic study of metformin to compare a voglibose/metformin fixed-dose combination with coadministered voglibose and metformin
por: Choi, Hyang-Ki, et al.
Publicado: (2015)

Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients
por: Firouzjaei, A, et al.
Publicado: (2016)

Response to Comment to the Article “Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?” [Response To Letter]
por: Dzięgielewska-Gęsiak, Sylwia, et al.
Publicado: (2022)

Metformin allergy
por: Wiwanitkit, Viroj
Publicado: (2011)

Metformin - For the dermatologist
por: Bubna, Aditya Kumar
Publicado: (2016)

Microalbuminuria in Hyperglycemic Critically Ill Patients Treated with Insulin or Metformin
por: Panahi, Yunes, et al.
Publicado: (2011)

Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk
por: Miele, Luca, et al.
Publicado: (2015)

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
por: Saleh, Hend S., et al.
Publicado: (2016)

Metformin Might Inhibit Virus through Increasing Insulin Sensitivity
por: Chen, Yong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_39nuv9c60i05hg6gn8dkntdup7